Rekah Pharmaceutical Industry Ltd Capital Reinvestment Ratio
Rekah Pharmaceutical Industry Ltd capital reinvestment ratio. Rekah Pharmaceutical Industry Ltd (REKA) has a Capital Reinvestment Ratio of 0.04x as of June 2026, meaning it reinvests 0% of its operating cash flow (ILA13.82 Million) in capital expenditures (ILA495.00K). Check how aggressively does Rekah Pharmaceutical Industry Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Rekah Pharmaceutical Industry Ltd (2002–2025)
Capital reinvestment ratio of Rekah Pharmaceutical Industry Ltd from 2002 to 2025. This chart tracks Rekah Pharmaceutical Industry Ltd's Capital Reinvestment Ratio across 21 annual periods. Also explore Rekah Pharmaceutical Industry Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Rekah Pharmaceutical Industry Ltd Capital Reinvestment Ratio by Year (2002–2025)
Rekah Pharmaceutical Industry Ltd capital reinvestment ratio by year from 2002 to 2025. For the full cash flow conversion analysis, see how efficiently does Rekah Pharmaceutical Industry Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | ILA12.95 Million | ILA7.03 Million | ▲ +65.5% |
| 2024 | 0.33x | ILA26.54 Million | ILA8.70 Million | ▼ -19.1% |
| 2023 | 0.41x | ILA28.35 Million | ILA11.49 Million | ▲ +111.3% |
| 2022 | 0.19x | ILA39.00 Million | ILA7.48 Million | ▼ -71.0% |
| 2021 | 0.66x | ILA21.17 Million | ILA13.99 Million | ▼ -60.4% |
| 2020 | 1.67x | ILA11.28 Million | ILA18.84 Million | ▲ +24.7% |
| 2019 | 1.34x | ILA33.91 Million | ILA45.40 Million | ▲ +52.5% |
| 2018 | 0.88x | ILA17.28 Million | ILA15.18 Million | ▲ +26.8% |
| 2017 | 0.69x | ILA23.80 Million | ILA16.48 Million | ▲ +17.6% |
| 2016 | 0.59x | ILA22.82 Million | ILA13.44 Million | ▼ -74.0% |
| 2015 | 2.26x | ILA5.81 Million | ILA13.15 Million | ▼ -84.4% |
| 2014 | 14.49x | ILA1.33 Million | ILA19.27 Million | ▲ +3767.8% |
| 2013 | 0.37x | ILA11.71 Million | ILA4.38 Million | ▼ -45.9% |
| 2012 | 0.69x | ILA14.18 Million | ILA9.82 Million | ▼ -40.8% |
| 2010 | 1.17x | ILA6.73 Million | ILA7.87 Million | ▲ +226.1% |
| 2009 | 0.36x | ILA26.03 Million | ILA9.33 Million | ▼ -78.0% |
| 2008 | 1.63x | ILA6.57 Million | ILA10.73 Million | ▲ +285.0% |
| 2007 | 0.42x | ILA12.45 Million | ILA5.28 Million | ▼ -74.4% |
| 2005 | 1.66x | ILA4.27 Million | ILA7.09 Million | ▲ +530.7% |
| 2004 | 0.26x | ILA17.87 Million | ILA4.70 Million | ▲ +20.9% |
| 2002 | 0.22x | ILA11.21 Million | ILA2.44 Million | — |